In accordance, monocytes from LR-MDS patients had significantly higher percentages of CD56+ cells, as compared to normal individuals (median values of 15% and 7%, ranging from 0 to 99% and from 0 to 15%, respectively; p = 0.026) (Fig. 5 and Table 5). This evidence concerns the gene NCAM1 and myelodysplastic syndrome.